Sequential Dosing in Chemosensitization: Targeting the PI3K/Akt/mTOR Pathway in Neuroblastoma

Erstveröffentlichung
2013Authors
Westhoff, Mike-Andrew
Faham, Najmeh
Marx, Daniela
Nonnenmacher, Lisa
Jennewein, Claudia
Wissenschaftlicher Artikel
Published in
PLoS ONE ; 8 (2013), 12. - Art.-Nr. e83128. - ISSN 1932-6203
Link to publication
https://dx.doi.org/10.1371/journal.pone.0083128Institutions
UKU. Klinik für Kinder- und JugendmedizinProject uulm
IGradU / International Graduate School der Universität Ulm
Subject headings
[Free subject headings]: high-risk neuroblastoma | cell-death | glioblastoma cells | metastatic neuroblastoma | multiple-myeloma | topoisomerase-ii | hela-cells | apoptosis | akt | activation[DDC subject group]: DDC 610 / Medicine & health